A detailed history of Pathstone Family Office, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Pathstone Family Office, LLC holds 23,623 shares of BDX stock, worth $5.29 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,623
Previous 11,580 104.0%
Holding current value
$5.29 Million
Previous $3.06 Million 99.77%
% of portfolio
0.04%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$254.9 - $283.59 $3.07 Million - $3.42 Million
12,043 Added 104.0%
23,623 $6.11 Million
Q2 2023

Jan 12, 2024

SELL
$238.39 - $265.32 $2.87 Million - $3.2 Million
-12,043 Reduced 50.98%
11,580 $3.06 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $1.21 Million - $1.34 Million
-5,066 Reduced 30.43%
11,580 $3.06 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $488,822 - $551,896
-2,128 Reduced 11.33%
16,646 $4.12 Million
Q4 2022

Oct 23, 2023

BUY
$218.29 - $256.91 $682,811 - $803,614
3,128 Added 19.99%
18,774 $4.78 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $216,980 - $255,368
-994 Reduced 5.03%
18,774 $4.78 Million
Q3 2022

Oct 23, 2023

BUY
$51.03 - $264.23 $184,677 - $956,248
3,619 Added 30.09%
15,646 $3.49 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $209,580 - $1.09 Million
4,107 Added 26.22%
19,768 $4.41 Million
Q2 2022

Oct 23, 2023

BUY
$234.74 - $275.42 $104,928 - $123,112
447 Added 3.86%
12,027 $2.97 Million
Q2 2022

Aug 15, 2022

BUY
$234.74 - $275.42 $553,282 - $649,164
2,357 Added 17.72%
15,661 $3.86 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $421,984 - $468,471
-1,732 Reduced 11.52%
13,304 $3.54 Million
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $1.5 Million - $1.64 Million
-6,541 Reduced 30.31%
15,036 $3.78 Million
Q3 2021

Nov 16, 2021

BUY
$232.72 - $256.47 $518,965 - $571,928
2,230 Added 11.53%
21,577 $5.3 Million
Q2 2021

Aug 31, 2021

SELL
$232.65 - $254.58 $669,334 - $732,426
-2,877 Reduced 12.95%
19,347 $4.7 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $1.19 Million - $1.32 Million
5,147 Added 30.14%
22,224 $5.4 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $47,490 - $52,631
214 Added 1.27%
17,077 $4.27 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $486,345 - $623,817
2,254 Added 15.43%
16,863 $3.92 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $23,089 - $27,658
-105 Reduced 0.71%
14,609 $3.5 Million
Q1 2020

Jun 11, 2020

BUY
$195.69 - $279.01 $2.86 Million - $4.07 Million
14,602 Added 13037.5%
14,714 $3.38 Million
Q1 2020

May 07, 2020

SELL
$195.69 - $279.01 $2.16 Million - $3.09 Million
-11,059 Reduced 99.0%
112 $25.7 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $35,231 - $39,756
149 Added 1.35%
11,171 $30.4 Million
Q3 2019

Nov 13, 2019

SELL
$230.58 - $256.08 $1.19 Million - $1.32 Million
-5,143 Reduced 31.82%
11,022 $2.79 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $5,217 - $5,905
24 Added 0.15%
16,165 $4.07 Million
Q1 2019

May 14, 2019

BUY
$206.05 - $248.17 $914,037 - $1.1 Million
4,436 Added 37.9%
16,141 $4.03 Million
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $2,456 - $3,095
12 Added 0.1%
11,705 $2.64 Million
Q3 2018

Nov 09, 2018

BUY
$233.07 - $256.0 $793,137 - $871,168
3,403 Added 41.05%
11,693 $3.05 Million
Q2 2018

Aug 10, 2018

SELL
$208.1 - $233.85 $1.21 Million - $1.36 Million
-5,799 Reduced 41.16%
8,290 $1.99 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $759,174 - $887,797
3,695 Added 35.55%
14,089 $3.05 Million
Q4 2017

Feb 12, 2018

BUY
$189.0 - $222.64 $1.21 Million - $1.43 Million
6,414 Added 161.16%
10,394 $2.23 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $2,803 - $2,983
15 Added 0.38%
3,980 $780,000
Q2 2017

Aug 16, 2017

BUY
N/A
3,965
3,965 $774,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.